NEW YORK (GenomeWeb) – Quidel today reported preliminary revenues for the fourth quarter of 2015 well below analyst forecasts.

Due to a weak influenza season, the firm now expects Q4 revenues between $52 million and $53 million, below analysts' consensus estimate of $64 million.

Investors reacted negatively to the news, sending Quidel's shares down around 7 percent to $17.67 in mid-morning trade on the Nasdaq. The shares had fallen to as low as $16.71 earlier in the session.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.